Douglas T. Sheehy, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 400 shares at $37.00 ($15K) on 2020-01-16, disclosed to the SEC on 2020-01-21.
Scheduled sale ($15k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AIMT | SELL | 2018-03-06 | $129K | — | Filing → |
| AIMT | SELL | 2018-02-07 | $118K | — | Filing → |
| AIMT | SELL | 2018-01-26 | $143K | — | Filing → |